ALDH2 and in situ carcinoma: It is likely that the enzymatic activity of ALDH1A1 and ALDH2, together with the high levels of ABC-transporters, accounts to the highly chemoresistance profile exhibited by sphere-forming cells to MTX and CIS treatment, which demonstrated efficacy against parental cells.